Drug having inhibitory action on transcription factor KLF5 activation

摘要

A medicament having the action of suppressing the activation of the transcription factor KLF5 and suppressing vascular remodeling and arteriosclerosis, comprising an acyclic polyprenyl compound (for example, 3,7,11,15-tetramethyl-2,4, 6,10,14-polydecenylcarboxylic acid such as hexadecapentaenoic acid)) as an active ingredient.